Back to search

France· FR:68053454

CIMETIDINE ARROW 200 mg, comprimé effervescent

A cimetidine product containing cimétidine, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A02BA01

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedCIMETIDINE ARROW 200 mg, comprimé eff…ATCA02BA01REGISTER NO.FR:68053454PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Cimetidine is registered in 11 of 19 countries.

Countries holding a registration under ATC A02BA01 (cimetidine), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 5 of them publish a price we can compare per daily dose

Cimetidine · ATC A02BA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cimetidine costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.

  • France: $1.63 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Cimetidine · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • FR France$1.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CIMÉTIDINE
Manufacturer
ARROW GENERIQUES
Country
France (FR)
ATC code
A02BA01
ATC class
Cimetidine
Defined daily dose
0.8 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400934882555
    3 tube(s) polypropylène de 20 comprimé(s)
    EUR 7.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

678 interactions on record for cimetidine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Cimetidine · interactions on record

678 records

  • 35 severe
  • 311 moderate
  • 153 minor
  • 169 info

Most severe, free to view

  • CisaprideA03FA02severe
  • LoperamideA07DA03severe
  • EliglustatA16AX10severe
  • LonafarnibA16AX20severe

10 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cimetidine in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cimetidine products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Austria · Cimetidin Genericon, Ulcostad
  • Cyprus · Tenomet, Ulcomet
  • Germany · H2-Blocker Ratiopharm
  • United Kingdom (Northern Ireland) · Cimetidine Accord Healthcare, Cimetidine Bristol Laboratories
  • Greece · Tagamet
  • Ireland · Cimeldine Clonmel Healthcare
  • Luxembourg · H2blocker
  • Netherlands · Cimetidine Accord, Cimetidine Cf
  • Portugal · Cim.
  • Romania · Cimetidina Arena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fcfff09e-72da-45c4-b208-c216024f7da5
GET /v1/drugs/fcfff09e-72da-45c4-b208-c216024f7da5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68053454",
  "date_amm": "1998-12-07",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CIMÉTIDINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé effervescent(e)",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about cimetidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.